Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

Published:2020-10 Issue: Volume:219 Page:108555
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Laurence Jeffrey,Mulvey J. Justin,Seshadri Madhav,Racanelli Alexandra,Harp Joanna,Schenck Edward J.,Zappetti Dana,Horn Evelyn M.,Magro Cynthia M.

Funder

Angelo Donghia Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area;Richardson;JAMA,2020

2. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterization Protocol: prospective observational cohort study;Docherty;BMJ,2020

3. Kidney disease is associated with in-hospital death of patients with COVID-19;Cheng;Kidney Int.,2020

4. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases;Magro;Transl. Res.,2020

5. COVID-19 and its implications for thrombosis and anticoagulation;Connors;Blood,2020

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein;Frontiers in Immunology;2024-06-07

2. mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions;International Journal of Molecular Sciences;2024-03-22

3. Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID;Med;2024-03

4. Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains;Diagnostic Pathology;2024-02-15

5. Genetic justification of COVID‐19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm;Journal of Cellular and Molecular Medicine;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3